"10.1371_journal.pone.0036847","plos one","2012-05-23T00:00:00Z","Jeffrey M Gelfand; Douglas S Goodin; W John Boscardin; Rachel Nolan; Ami Cuneo; Ari J Green","University of California, San Francisco Department of Neurology, Multiple Sclerosis Center, University of California San Francisco, San Francisco, California, United States of America; Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America","Conceived and designed the experiments: JMG AJG. Performed the experiments: JMG RN AC AJG. Analyzed the data: JMG DSG WJB RN AC AJG. Wrote the paper: JMG DSG WJB AJG.","The authors have read the journal's policy and have the following conflicts: Jeffrey Gelfand: Dr. Gelfand has received honoraria from the National MS Society for patient education and has received compensation for writing for Journal Watch Neurology. Douglas Goodin: Consultant for Teva, Novartis and Serono, Advisor/Consultant for Bayer. W. John Boscardin: Nothing to disclose. Rachel Nolan: Nothing to disclose. Ami Cuneo: Nothing to disclose. Ari Green: Advisor to Novartis on the use of Optical Coherence Tomography in MS and Service on the Endpoint Adjudication Committee for Applied Clinical Intelligence/Biogen-Idec. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","05","Jeffrey M Gelfand","JMG",6,TRUE,2,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
